Abstract
Advances in nanotechnology have led to the fabrication of nano-constructs of organic or inorganic origins with well-defined structures, surface properties, and can be made to respond to physical or chemical stimuli. These nano-constructs can provide a shift in the way diagnostic and therapeutic drugs are delivered to achieve target specificity and increased retention of therapeutic doses for considerable improvement in the overall treatment of the tumors. In this case we describe here a synthetic approach to glycopolymer base nanoparticle gold(I) conjugate for cancer therapy.
| Original language | English |
|---|---|
| Title of host publication | Methods in Molecular Biology |
| Publisher | Humana Press Inc. |
| Pages | 157-168 |
| Number of pages | 12 |
| DOIs | |
| Publication status | Published - 2016 |
Publication series
| Name | Methods in Molecular Biology |
|---|---|
| Volume | 1367 |
| ISSN (Print) | 1064-3745 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Glyconanoparticles
- Glycopolymer
- Gold(I) triphenylphosphine
- Target specificity
ASJC Scopus subject areas
- Molecular Biology
- Genetics
Fingerprint
Dive into the research topics of 'Synthetic approach to glycopolymer base nanoparticle gold(I) conjugate: A new generation of therapeutic agents'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver